Chemical Compound

Bumetanide; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-; Benzoic acid, 3-(butylamino)-4-phenoxy-5-sulfamoyl- (8CI); 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-ph

CAS Registry Number 28395-03-1
Bumetanide; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-; Benzoic acid, 3-(butylamino)-4-phenoxy-5-sulfamoyl- (8CI); 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-ph 结构式
Primary record

Bumetanide; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-; Benzoic acid, 3-(butylamino)-4-phenoxy-5-sulfamoyl- (8CI); 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-ph

库存
3,852 克
纯度
99.8 %
CAS
28395-03-1

化合物标识与属性

CAS
28395-03-1
PubChem CID
2471
SMILES
CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
Canonical SMILES
CCCCNc1cc(C(=O)O)cc(S(N)(=O)=O)c1Oc1ccccc1

名称与同义词

  • bumetanide
  • Bumex
  • Burinex
  • Fordiuran
  • Lunetoron
  • Bumetanida
  • 28395-03-1
  • Fontego
  • Segurex
  • Bumetanidum
  • Bumethanide
  • Lixil
  • 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid
  • Aquazone
  • Bufenox
  • Butinat
  • Cambiex
  • Diurama
  • Yurinex
  • Burine
  • Lixil-Leo
  • Drenural
  • Bumedyl
  • Miccil
  • Bumetanide-d5
  • Lunetron
  • Betinex
  • Bumetanidum [INN-Latin]
  • Bumetanide?
  • Bumetanida [INN-Spanish]
  • Bumetanide CRS
  • Bumex, Bumetanide
  • Bumetanide in bulk
  • Ro 10-6338
  • Bumex (TN)
  • Prestwick_679
  • Bumetanide Leo Brand
  • ENBUMYST
  • Bumetanide (Standard)
  • PF 1593
  • Bumetanide Roche Brand
  • C17H20N2O5S
  • 0Y2S3XUQ5H
  • Spectrum_001317
  • Bumetanide (JP15/USP)
  • Bumetanide, >=98%
  • BUMETANIDE [MI]
  • Leo Brand of Bumetanide
  • RefChem:57582
  • UNII-0Y2S3XUQ5H
  • DTXSID5022699
  • BUMETANIDE [INN]
  • BUMETANIDE [JAN]
  • PF-1593
  • Bumetanide Atlantis Brand
  • Opera_ID_1734
  • Prestwick0_000276
  • Prestwick1_000276
  • Prestwick2_000276
  • Prestwick3_000276
  • Spectrum2_001050
  • Spectrum3_001481
  • Spectrum4_000030
  • Spectrum5_001212
  • BUMETANIDE [USAN]
  • CHEBI:3213
  • Lopac-B-3023
  • MAEIEVLCKWDQJH-UHFFFAOYSA-N
  • Roche Brand of Bumetanide
  • Bumetanide Farmacusi Brand
  • Bumetanide Grossmann Brand
  • Bumetanide Senosiain Brand
  • BUMETANIDE [VANDF]
  • PF1593
  • D0R7HO
  • Epitope ID:613420
  • 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid
  • AC1L1DR5
  • BUMETANIDE [MART.]
  • cid_2471
  • MLS000028457
  • Bumetanide AstraZeneca Brand
  • DTXCID702699
  • Atlantis Brand of Bumetanide
  • BUMETANIDE [USP-RS]
  • BUMETANIDE [WHO-DD]
  • CHEMBL1072
  • Bumetanide (Ro 10-6338)
  • Bumetanide [USAN:BAN:INN:JAN]
  • Lopac0_000162
  • SCHEMBL27525
  • BSPBio_000152
  • BSPBio_001508
  • BSPBio_003061
  • KBioGR_000228
  • KBioGR_000439
  • KBioSS_000228
  • KBioSS_001797
  • Ro-10-6338
  • Farmacusi Brand of Bumetanide
  • Grossmann Brand of Bumetanide
  • MLS001148265
  • orb134445
  • Senosiain Brand of Bumetanide
  • Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-
  • DivK1c_000034
  • SPECTRUM1502004
  • EINECS 249-004-6
  • SPBio_000980
  • SPBio_002371
  • MFCD00078949
  • AstraZeneca Brand of Bumetanide
  • BPBio1_000168
  • Bumetanide (JP15/USP/INN)
  • Bumetanide (JP18/USP/INN)
  • GTPL4837
  • BUMETANIDE [EP IMPURITY]
  • BUMETANIDE [ORANGE BOOK]
  • Ro-106338
  • SCHEMBL29388271
  • BDBM25903
  • CTK8B4560
  • ERK5-2L13
  • HMS500B16
  • KBio1_000034
  • KBio2_000228
  • KBio2_001797
  • KBio2_002796
  • KBio2_004365
  • KBio2_005364
  • KBio2_006933
  • KBio3_000455
  • KBio3_000456
  • KBio3_002561
  • BRN 2185351
  • BUMETANIDE [EP MONOGRAPH]
  • C03CA02
  • CID2471
  • NINDS_000034
  • Bio1_000421
  • Bio1_000910
  • Bio1_001399
  • Bio2_000228
  • Bio2_000708
  • BUMETANIDE [USP MONOGRAPH]
  • HMS1361L10
  • HMS1568H14
  • HMS1791L10
  • HMS1921B20
  • HMS1989L10
  • HMS2089P13
  • HMS2092N03
  • HMS2095H14
  • HMS2230P15
  • HMS3259O08
  • HMS3260B05
  • HMS3374E02
  • HMS3402L10
  • HMS3654B13
  • HMS3712H14
  • HMS3873C13
  • HMS5079F07
  • Pharmakon1600-01502004
  • Bumetanide [USAN:INN:BAN:JAN]
  • BCP28485
  • Bumetanide [USAN:USP:INN:BAN:JAN]
  • CID:2471
  • KS-00000XN2
  • MSK10495
  • ZINC3813061
  • RO10-6338
  • Tox21_110088
  • Tox21_500162
  • 3-butylamino-4-phenoxy-5-sulfamoylbenzoic acid
  • ANW-45473
  • C17-H20-N2-O5-S
  • CCG-40125
  • CS-380
  • EBC-04409
  • HY-17468R
  • NCGC00015149-02
  • NSC758145
  • s1287
  • 3-butylamino-4-phenoxy-5-sulfamoyl-benzoic acid
  • SMR000058418
  • 3-butylamino-4-(phenoxy)-5-sulfamoylbenzoic acid
  • AKOS015896600
  • Tox21_110088_1
  • AC-8115
  • ACN-037986
  • AN-8345
  • CS-1821
  • CS-O-00982
  • DB00887
  • FB19354
  • J3.168B
  • KS-5211
  • LP00162
  • NC00550
  • NE48825
  • NSC 758145
  • NSC-758145
  • SDCCGSBI-0050150.P004
  • CAS-28395-03-1
  • IDI1_000034
  • IDI1_033978
  • Ro 10-6338;PF 1593
  • SMP1_000049
  • NCGC00015149-01
  • NCGC00015149-03
  • NCGC00015149-04
  • NCGC00015149-05
  • NCGC00015149-06
  • NCGC00015149-07
  • NCGC00015149-08
  • NCGC00015149-09
  • NCGC00015149-10
  • NCGC00015149-11
  • NCGC00015149-12
  • NCGC00015149-13
  • NCGC00015149-15
  • NCGC00015149-16
  • NCGC00015149-26
  • NCGC00022072-03
  • NCGC00022072-04
  • NCGC00022072-05
  • NCGC00022072-06
  • NCGC00022072-07
  • NCGC00022072-08
  • NCGC00260847-01
  • AJ-45693
  • BC208864
  • CPD000058418
  • HY-17468
  • LS-36330
  • S95008.
  • SAM002564195
  • SC-12128
  • SID:53788042
  • 3-(butylamino)-4-phenoxy-5-sulfamoyl-benzoic acid
  • B 3023
  • BENZOIC ACID, 3-(BUTYLAMINO)-4-PHENOXY-5-SULFAMOYL-
  • S-95008.
  • SBI-0050150.P003
  • AB0012138
  • AB2000031
  • ST2404803
  • TC-134218
  • A1855
  • AB00052253
  • EU-0100162
  • NS00009049
  • ST51014910
  • SW196834-3
  • A10167
  • D00247
  • EN300-122330
  • J10080
  • 3-butylamino-4-phenoxy-5-sulphamyl-benzoic acid
  • AB00052253-15
  • AB00052253-16
  • AB00052253_17
  • AB00052253_18
  • 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-benzoic acid
  • 3-n-butylamino-4-phenoxy-5-sulfamyl-benzoic acid
  • 3-n-butylamino-4-phenoxy-5-sulphamyl-benzoic acid
  • 395B031
  • A819434
  • D002034
  • Q275926
  • SR-01000003062
  • I06-2277
  • SR-01000003062-2
  • SR-01000003062-4
  • SR-01000003062-7
  • 3-(aminosulfonyl)-5-(butylamino)-4-(phenyloxy)benzoic acid
  • BRD-K38197229-001-06-7
  • BRD-K38197229-001-17-4
  • BRD-K38197229-001-28-1
  • BRD-K38197229-001-29-9
  • Z1541758727
  • Bumetanide, British Pharmacopoeia (BP) Reference Standard
  • Bumetanide, European Pharmacopoeia (EP) Reference Standard
  • Bumetanide, United States Pharmacopeia (USP) Reference Standard
  • 1216739-35-3
  • 3-(butylamino)-4-(2,3,4,5,6-pentadeuteriophenoxy)-5-sulfamoylbenzoic acid
  • Ro 10-6338; PF 1593 pound>>Ro-10-6338; PF1593 pound>>Ro10-6338; PF-1593
  • 249-004-6
  • 82U
  • Bumetanide; 3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid; Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-; Benzoic acid, 3-(butylamino)-4-phenoxy-5-sulfamoyl- (8CI); 3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid; 3-(Butylamino)-4-ph